MoneyWorks4Me

Zydus Lifesciences informs about disclosure

24 Apr 2024 Evaluate
Zydus Lifesciences has informed that the USFDA conducted an inspection at the Injectable Manufacturing site situated at Jarod, near Vadodara. The inspection was conducted from April 15 to April 23, 2024. The inspection closed with 10 observations. The Company will closely work with the USFDA to address and respond to the observations in an expeditious manner. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1114.00 -3.00 (-0.27%)
19-Aug-2026 11:07 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1890.00
Dr. Reddys Labs. 1180.40
Cipla 1425.05
Lupin 2216.70
Zydus Lifesciences 1114.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: